Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO  
11.92
+1.03 (+9.46%)
Positive Earnings Pre-Announcement

Aziyo Biologics Reports Q1 2021 Financial Results And Increases 2021 Revenue Guidance

Published: 05/04/2021 20:40 GMT
Aziyo Biologics Inc - Ordinary Shares - Class A (AZYO) - Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance.
Q1 Loss per Share $0.50.
Sees FY Sales $52 Million to $54 Million.
Q1 Sales Rose 31 Percent to $12.9 Million.
Revenue is expected to be $12.7 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $13.4 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.